Low-Fat, High Fruit and Vegetable Diets and Weight Loss Do Not Affect Biomarkers of Cellular Proliferation in Barrett Esophagus
- Alan R. Kristal1,4,8,
- Patricia L. Blount2,5,
- Jeannette M. Schenk1,4,
- Carissa A. Sanchez2,
- Peter S. Rabinovitch6,
- Robert D. Odze9,
- Judi Standley1,
- Thomas L. Vaughan3,4 and
- Brian J. Reid2,5,7
- 1Cancer Prevention Program, 2Divisions of Human Biology and Public Health Sciences, and 3Epidemiology Program, Fred Hutchinson Cancer Research Center; Departments of 4Epidemiology, 5Medicine, 6Pathology, and 7Genome Sciences and 8Program in Nutritional Sciences, University of Washington, Seattle, Washington; and 9Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
- Requests for reprints:
Alan Kristal, Fred Hutchinson Cancer Research Center, Cancer Prevention Program, M4-B402, P.O. Box 19024, Seattle, WA. Phone: 206-667-4686; Fax: 206-667-5977. E-mail: akristal{at}fhcrc.org
Abstract
Risk factors for esophageal adenocarcinoma include obesity, high fat intake, and low consumption of fruits and vegetables. This trial tested whether an intervention to reduce these risk factors in patients with Barrett esophagus, a preneoplastic condition for esophageal adenocarcinoma, could reduce biomarkers of cellular proliferation and, by inference, the risk of neoplastic progression. Eighty-seven men and women with Barrett esophagus were randomized to an intensive dietary intervention or control group. At baseline, 18 and 36 months after intervention, biopsies were obtained at 2-cm intervals throughout the length of the Barrett segment. Ki67/DNA content flow cytometry was used to assess (a) % Ki67-positive proliferating diploid G1 cells, (b) % total Ki67-positive proliferating cells, (c) presence of aneuploidy, and (d) presence of >6% of cells in the 4N (G2/tetraploid) fraction of the cell cycle. We also assessed re-epithelialization and length of the Barrett segment, reflux symptoms, and medication use. The intervention effects for energy, fat, fruits and vegetables, and weight were, respectively, −314 kcal, −12.2% energy, 1.8 servings/d, and −4.0 kg at 18 months (all P < 0.005) and were smaller but remained significant at 36 months. There were no significant effects of the intervention on any biomarker of cellular proliferation. The intervention effects ± SE for mean %G1 Ki67+ cells were 0.98 ± 1.58 at 18 months and 1.79 ± 1.31 at 36 months; the relative risks (95% confidence interval) for developing >6% of cells in 4N were 0.5 (0.1-2.6) at 18 months and 0.75 (0.2-3.1) at 36 months. A single control participant developed aneuploidy. There were no significant effects on re-epithelialization, segment length, or reflux medication use. We conclude that substantial dietary change has no short-term effects on biomarkers of cellular proliferation in Barrett esophagus or on clinical observations of the Barrrett segment.
- Barrett esophagus
- Esophageal adenocarcinoma
- Diet and cancer
- Prevention and treatment of premalignant lesions (IENs)
- Biomarkers and intervention studies
- Gastrointestinal cancers: other
Footnotes
-
Grant support: NIH grants U01 CA62548 and P01 CA91955.
-
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Accepted August 12, 2005.
- Received March 3, 2005.
- Revision received July 28, 2005.










